Legal Representation
Attorney
Jonathan A. Menkes
USPTO Deadlines
Next Deadline
1702 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-02)
Due Date
April 02, 2030
Grace Period Ends
October 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 2, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 2, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 16, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 16, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 27, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 13, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Dec 8, 2023 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Dec 1, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 1, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 1, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 29, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Nov 8, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 8, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 8, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 12, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 12, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 25, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 25, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 28, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 28, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 28, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 9, 2022 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Nov 9, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 26, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Sep 23, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 23, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biopharmaceuticals and medicines in the form of cell suspension for IV infusion for cell and gene therapy during cancer treatment; biopharmaceuticals and medicines in the form of cell suspension for IV infusion for the treatment of cancer
Class 044
Medical services; medical treatment services in the nature of providing personalized medicine to patients during the treatment of cancer; medical services in the nature of providing medical treatment through the provision of cell and gene therapy medicines and therapeutics; medical treatment services, namely, medical treatment of cancer by delivering cell and gene therapy medicines via IV infusion
Classification
International Classes
005
044